Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 3, 2002, Pages 633-638

  Jones, Les P ^a   Zheng, Hao Qiang ^a   Karron, Ruth A ^a   Peret, Teresa C T ^a   Tsou, Cecelia ^a   Anderson, Larry J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; GUANINE NUCLEOTIDE BINDING PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; COVALENT BOND; FLOW CYTOMETRY; GENOTYPE; HUMAN; IMMUNOASSAY; INFANT; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SERUM; STRAIN DIFFERENCE; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD, PRESCHOOL; HUMANS; INFANT; MICE; MICE, INBRED BALB C; PEPTIDES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VACCINES, ATTENUATED; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0036109429     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.3.633-638.2002     Document Type: Article

References (42)

1. Multicenter study of strains of respiratory syncytial virus
2. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies
3. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus
4. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city
5. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses
6. Evolution of subgroup A respiratory syncytial virus: Evidence for progressive accumulation of amino acid changes in the attachment protein
7. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection
8. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test
9. Antigenic differences between two strains of respiratory syncytial virus
10. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
11. Respiratory syncytial virus (RSV) may be an important cause of community-acquired lower respiratory tract infection among hospitalized adults
12. Respiratory syncytial virus vaccines
13. Epidemic infections caused by respiratory syncytial virus in institutionalized young adults
14. Evolutionary pattern of human respiratory syncytial virus (subgroup A): Cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein
15. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein
16. National surveillance for respiratory syncytial virus, United States, 1985-1990
17. Respiratory syncytial viral infection in children with compromised immune function
18. Occurrence of groups A and B of respiratory syncytial virus over 15 years: Associated epidemiologic and clinical characteristics in hospitalized and ambulatory children
19. Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden
20. Respiratory-syncytial-virus infections, reinfections and immunity: A prospective, longitudinal study in young children
21. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus
22. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: Evaluation of the contributions of F and G glycoproteins to immunity
23. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins
24. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
25. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children
26. Respiratory syncytial viral infection in infants with congenital heart disease
27. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein
28. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections
29. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections
30. Two, distinct subtypes of human respiratory syncytial virus
31. Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus
32. The G protein of human respiratory syncytial virus: Significance of carbohydrate side-chains and the C-terminal end to its antigenicity
33. Epidemiology of respiratory syncytial virus infection in Washington D.C. II. Infection and disease with respect to age, immunologic status, race and sex
34. Circulation patterns of group A and B human respiratory synyctial virus genotypes in five communities in North America
35. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community
36. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus
37. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses
38. Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children
39. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse
40. Pattern of respiratory syncytial virus epidemics in Finland: Two-year cycles with alternating prevalence of groups A and B